登录

inCarey Secured ¥30M in Series B+ Round of Financing

作者: Mailman 2020-09-15 09:28
云开亚美
http://www.incarey.cn/
企业数据由 动脉橙 提供支持
互联网多专科数字医疗服务平台 | C轮 | 运营中
中国-浙江
2021-12-22
融资金额:RMB¥2亿
恩颐投资(中国)
查看

According to VCBeat, Zhejiang Yunkai Yamei Pharmaceutical Technology Co., Ltd. ("inCarey") has secured US$ 30 million in a Series B+ round from Long Hill Capital. China Renaissance served as the exclusive financial adviser in this round of financing.


inCarey is committed to building a comprehensive service platform for chronic diseases and major diseases in China, with the most comprehensive medical service and operation system of single diseases. inCarey operates a retail chain of stores in China, intended to provide various pharmaceuticals for major diseases. The company's online platform is cloud-based and offers professional disease management services, along with one-on-one interaction of doctors with patients and an internet retail platform, enabling the users to receive medicines for major diseases through the e-commerce platform.


Liu Yunjiang, founder and CEO of inCarey, said that the funds raised will be mainly used to further strengthen the online service system, expand the scale of patients and cover more diseases.


inCarey connects doctors, patients and drug companies and provides service in the whole course of the disease with all prescription and channels, and through the network with doctors and pharmacists and digital tools, it can achieve better management of chronic and major diseases.


The whole course management system developed by inCarey covers visits of doctors, examining, drug therapy, surgical treatment, rehabilitation medicine and postoperative follow-up. It provides one-stop therapy management services for patients, follow-up and clinical data for doctors, and medication compliance management for drug companies to expand their product sales.


>>>>

About Long Hill Capital 


Long Hill Capital is a next-generation thesis-driven venture capital firm. It invests in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese.


Over the course of their venture capital careers, the Long Hill Capital team has invested in such industry-leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.

相关赛道 数字疗法
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

CHIC Health Raises ¥10M in Angel Round of Financing

Standard Medical Secures ¥10M in Strategic Financing, To Provide Closed-Loop Hypertension Management

Zhiyun Health Snags $144M in its Series C+ and Series D Financing

【首发】硅基仿生再获近5亿元D轮融资,加速实现血糖管理模式数字化升级

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

翻阅20家医疗服务企业年中报后,我们发现这四个行业趋势

2020-09-15
下一篇

GemPharmatech Raises ¥400M in Series B Funding Round

2020-09-15